Seeing Is Believing
Healthcare - Sector
Cortexyme's activity chart (see below) currently has 16 price targets and 19 ratings on display.
Analysts average stock forecasts to be materialized ratio is 77.5% with an average time for these price targets to be met of 159.92 days.
Most recent stock forecast was given by JUDAH FROMMER from MORGAN STANLEY on 11-May-2022. First documented stock forecast 03-Jun-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 26-Apr-2021
$3.5
$2.17 (163.16%)
$14
4 years 2 months 24 days ago
(11-May-2022)
1/2 (50%)
$0.36 (11.46%)
184
Buy Since 05-Apr-2022
4 years 4 months ago
(05-Apr-2022)
1/2 (50%)
$59.58 (65.89%)
15
Buy Since 24-Jun-2020
$15
$13.67 (1027.82%)
$30
4 years 4 months 26 days ago
(09-Mar-2022)
2/5 (40%)
$10.18 (211.20%)
293
Hold Since 27-Jan-2022
$53
4 years 6 months 9 days ago
(27-Jan-2022)
1/1 (100%)
$28.87 (119.64%)
200
Sell Since 11-Dec-2020
$5
4 years 8 months 24 days ago
(11-Nov-2021)
3/3 (100%)
$-8.51 (-62.99%)
155
What is CRTX (Cortexyme) average time for price targets to be met?
Which analyst has the current highest performing score on CRTX (Cortexyme) with a proven track record?
Which analyst has the most public recommendations on CRTX (Cortexyme)?
Which analyst is the currently most bullish on CRTX (Cortexyme)?
Which analyst is the currently most reserved on CRTX (Cortexyme)?